Tanaka, H., Soga, F., Tatsumi, K., Mochizuki, Y., Sano, H., Toki, H., . . . Hirata, K. (2020). Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure. Cardiovasc Diabetol.
Chicago-stil citatTanaka, Hidekazu, et al. "Positive Effect of Dapagliflozin On Left Ventricular Longitudinal Function for Type 2 Diabetic Mellitus Patients With Chronic Heart Failure." Cardiovasc Diabetol 2020.
MLA-referensTanaka, Hidekazu, et al. "Positive Effect of Dapagliflozin On Left Ventricular Longitudinal Function for Type 2 Diabetic Mellitus Patients With Chronic Heart Failure." Cardiovasc Diabetol 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.